Truepill stops Adderall prescriptions, heart algorithm mines Apple Watch data and home health sees gold rush

Truepill stops stimulant prescriptions

The online pharmacy realpill is temporarily halting prescriptions for Adderall and other controlled substances used to treat ADHD, as concerns grow that some telehealth startups are prescribing these drugs too generously, reports the Wall Street Journal. Truepill, which did not provide a list of customers, said it was acting on the side of caution.

But his decision came amid an extensive review of prescribing practices in the Cerebral, a digital mental health company that describes Truepill as its favorite pharmacy. A former employee of the company has filed a whistleblower complaint alleging he was fired after raising concerns that the company was not following police prescriptions for stimulants, according to Bloomberg Law. Others have raised concerns that Cerebral is targeting teens and young adults with social media marketing.


Meanwhile, Cerebral’s chief medical officer, David Mou, defended the company’s practices at the annual conference of the American Telemedicine Association in Boston, Mobihealthnews reported. “At no time do we pressure clinicians to prescribe anything,” said Mou, who added that patients complete a screening form and get a 30-minute assessment, or 60 minutes for taking opioids. Mou acknowledged issues with marketing campaigns that had been outsourced, but said those messages are currently being reviewed by a clinical quality specialist.

Mayo Clinic detects heart problems on Apple Watch


A new study by researchers from Mayo Clinic establishes the feasibility of using an algorithm to detect weak heart pump from electrocardiograms recorded on apple watch. If validated in additional tests, the algorithm would allow users to detect the life-threatening condition outside of medical settings, allowing for earlier treatment. Perhaps more importantly, the study established that such tests can be performed rapidly on large populations in a decentralized trial. In its study to test the algorithm on single-lead ECG data, Mayo quickly collected 125,000 Apple Watch ECGs from more than 2,400 participants in 46 US states and 11 countries. Casey has the whole story.

The rush for home health is on

Major health systems, insurers and tech giants are uniting in lobbying efforts to allow more medical services to be delivered and reimbursed at home. Amazon is perhaps the biggest company to get involved Relocation of the health centera pressure group seeking to expand home health services paid for by Health Insurance. But a broad group of providers, legislators and interest groups are also involved in the quest. Mohana has a look breaking down the greatest players and how they fit into the bigger picture.

A big data approach to the long Covid

As patients and providers struggle to understand and treat the long Covid, machine learning researchers are turning to real-world data to see what insights they can glean. A team with National Covid Cohort Collaborativea huge centralized database of electronic health records that includes more than 13 million patients, uses algorithms to group together the many scattered symptoms that characterize the long Covid.

“If we’re able to identify these kind of constellations of symptoms that make up these potential long Covid subtypes…we might find that long Covid isn’t one disease, but it’s five diseases or 10 diseases “said Emily Pfaff, co of the team. -carry out. Ultimately, Pfaff said, these classifiers could be used to support recruitment for prospective studies of the syndrome and potential treatments. Katie has the whole story.

Skin cancer algorithms fall short in the real world

Diagnosing skin cancer is a prime area of ​​research and development in artificial intelligence, with some models showing even greater accuracy than that of dermatologists. But a large-scale validation challenge of 129 predictive algorithms showed that even the best performers miss their mark when applied to images that reflect the complexity of clinical practice. When presented with image sets that included diseases it was not trained on, the best algorithm achieved accurate results less than 60% of the time. And among the images of these new diseases, the top 25 algorithms mislabeled them as malignant 47% of the time – a warning against deploying automated diagnostics until it’s clear they won’t lead to overtreatment. .

Dollars and offers

  • The monitoring company BioIntelliSense signed a partnership with UC Davis Health to enable more virtual care across the healthcare system. BioIntelliSense announces wearable devices capable of monitoring more than 20 physiological signals for up to 30 days.
  • Digital start-up in heart health hello heart raised $70 million in a Series D round led by Grooves. Hello Heart creates a mobile app that uses personalized coaching to help people prevent heart disease.
  • Sema4a data analytics company, completed the acquisition of GeneDx, which specializes in testing and analyzing genomic data for rare diseases. Katherine Stueland, former CEO of GeneDx, will serve as CEO of the combined company.
  • Software as a service company Element5 raised $30 million in a Series B round led by Insight Partners. Company builds digital assistants to support administrative tasks for post-acute care

Harness new talent

  • Wearable heart monitoring company iRhythm appointed Mintu Turakhia, founding director of Stanford Digital Health Center, as the first Chief Medical Officer and Scientific Director. Simultaneously, clinical director Judy Lenane is retiring from the company.
  • the American Telemedicine Association has called on Kristi Henderson to chair its board of directors. Henderson is CEO of Optum Everycarewhich focuses on creating virtual care products.

What we read